Editorial: Dynamics of endocrine system dysfunctions and neuro-ophthalmic manifestations: early diagnostic to therapeutic implications - Scorecard - MDSpire

Editorial: Dynamics of endocrine system dysfunctions and neuro-ophthalmic manifestations: early diagnostic to therapeutic implications

  • By

  • Kumar, Dhiraj

  • Naqvi, Ahmad Abu Turab

  • Gupta, Rohan

  • Kumari, Smita

  • Waseem, Rashid

  • Hassan, Md. Imtaiyaz

  • May 31, 2026

  • 0 min

Share

Clinical Scorecard: The Interplay of Endocrine Dysfunction and Neuro-Ophthalmic Symptoms: Implications for Early Diagnosis and Treatment

At a Glance

CategoryDetail
ConditionEndocrine dysfunction and neuro-ophthalmic symptoms
Key MechanismsBidirectional relationship between endocrine and nervous systems; neuro-ophthalmic manifestations as indicators of systemic disturbances.
Target PopulationPatients with systemic endocrinopathies such as diabetes mellitus and thyroid disorders.
Care SettingIntegrated patient care settings focusing on early diagnosis and treatment.

Key Highlights

  • Neuro-ophthalmic manifestations can serve as early indicators of underlying endocrinopathies.
  • MicroRNAs play a critical role in retinal neurodegeneration and vascular permeability.
  • Advanced imaging techniques improve diagnostic accuracy for thyroid-associated ophthalmopathy.
  • Objective biomarkers can predict diabetic peripheral neuropathy before overt symptoms appear.
  • Targeted biological therapies are emerging as alternatives to broad immunosuppression in endocrine disorders.

Guideline-Based Recommendations

Diagnosis

  • Utilize advanced neuroimaging techniques for precise staging of thyroid-associated ophthalmopathy.
  • Incorporate standardized Ocular Surface Disease Index evaluations in Graves' Orbitopathy.

Management

  • Consider molecular targeting and precision medicine approaches in treating endocrine dysfunctions.

Monitoring & Follow-up

  • Monitor biomarkers such as serum uric acid levels and extracellular to total body water ratio for predicting diabetic neuropathy.

Risks

  • Elevated serum uric acid levels are an independent risk factor for diabetic peripheral neuropathy.

Patient & Prescribing Data

Patients with diabetes mellitus and thyroid disorders experiencing neuro-ophthalmic symptoms.

MiRNA-based interventions may actively repair neural architecture and reverse endothelial damage.

Clinical Best Practices

  • Recognize neuro-ophthalmic symptoms as potential early signs of systemic endocrine dysfunction.
  • Employ objective diagnostic metrics to enhance early detection and intervention.

Related Resources & Content

Original Source(s)

Editorial: Dynamics of endocrine system dysfunctions and neuro-ophthalmic manifestations: early diagnostic to therapeutic implications

  • by Kumar, Dhiraj , Naqvi, Ahmad Abu Turab , Gupta, Rohan , Kumari, Smita , Waseem, Rashid , Hassan, Md. Imtaiyaz

  • May 31, 2026

Related Content

Staging and Practical Management of Diabetic Retinopathy

Approximately half of patients who have severe NPDR and nearly 75% of patients who have very severe NPDR will progress to PDR within 1 year.

Comparative study of the therapeutic effects of different medications on DM-associated dry eye syndrome after vitrectomy

Diabetes Mellitus Coding in Retina

Age-related macular degeneration (AMD) is among the most common retinal diagnoses. Although the clinical features of the disease are well known, ICD-10 coding can be confusing if details such as stage, activity, and laterality are not clearly documented. Incomplete documentation may prompt questions about the medical necessity of diagnostic tests or intravitreal injections. This Q&A addresses common sources of confusion and offers practical guidance to support clear, accurate documentation.